TRAVOPROST

N/A

Manufactured by Novartis Pharmaceuticals Corporation

13,183 FDA adverse event reports analyzed

Last updated: 2026-04-14

About TRAVOPROST

TRAVOPROST is a medication tracked in the FDA Adverse Event Reporting System (FAERS), manufactured by Novartis Pharmaceuticals Corporation. The most commonly reported adverse reactions for TRAVOPROST include TREATMENT FAILURE, DRUG INEFFECTIVE, OCULAR HYPERAEMIA, EYE IRRITATION, EYE PAIN. This page provides a comprehensive breakdown of reported side effects, safety signals, patient demographics, and AI-powered safety analysis for TRAVOPROST.

Top Adverse Reactions

TREATMENT FAILURE1,945 reports
DRUG INEFFECTIVE528 reports
OCULAR HYPERAEMIA490 reports
EYE IRRITATION478 reports
EYE PAIN336 reports
INTRAOCULAR PRESSURE INCREASED295 reports
HYPERSENSITIVITY269 reports
FATIGUE261 reports
GLAUCOMA255 reports
VISION BLURRED227 reports
DIZZINESS226 reports
HEADACHE226 reports
VISUAL IMPAIRMENT215 reports
DEATH204 reports
DYSPNOEA197 reports
FALL186 reports
DIARRHOEA182 reports
NAUSEA181 reports
MALAISE178 reports
OFF LABEL USE178 reports
EYE PRURITUS154 reports
PRODUCT DOSE OMISSION ISSUE150 reports
COUGH146 reports
PAIN146 reports
ASTHENIA144 reports
DRY EYE140 reports
ARTHRALGIA133 reports
DRUG HYPERSENSITIVITY124 reports
PAIN IN EXTREMITY108 reports
PNEUMONIA108 reports
CATARACT106 reports
BLINDNESS105 reports
PRURITUS103 reports
CONSTIPATION100 reports
EYE DISORDER94 reports
WEIGHT DECREASED94 reports
HYPOACUSIS90 reports
INSOMNIA90 reports
PRODUCT QUALITY ISSUE90 reports
BACK PAIN89 reports
RASH89 reports
VOMITING89 reports
DECREASED APPETITE87 reports
HYPERTENSION86 reports
PYREXIA85 reports
BLOOD PRESSURE INCREASED84 reports
CONFUSIONAL STATE84 reports
NASOPHARYNGITIS84 reports
CONDITION AGGRAVATED81 reports
NO ADVERSE EVENT81 reports
RHINORRHOEA81 reports
URINARY TRACT INFECTION77 reports
OCULAR DISCOMFORT76 reports
PRODUCT CONTAINER ISSUE76 reports
FEELING ABNORMAL75 reports
LACRIMATION INCREASED75 reports
PRODUCT PACKAGING QUANTITY ISSUE75 reports
INCORRECT DOSE ADMINISTERED74 reports
ASTHMA72 reports
PERIPHERAL SWELLING72 reports
ACUTE KIDNEY INJURY71 reports
DEHYDRATION71 reports
ANAEMIA70 reports
EYE SWELLING68 reports
GAIT DISTURBANCE68 reports
SOMNOLENCE68 reports
ERYTHEMA67 reports
VISUAL ACUITY REDUCED66 reports
NASAL CONGESTION65 reports
ANXIETY64 reports
FOREIGN BODY SENSATION IN EYES63 reports
DEPRESSION61 reports
WEIGHT INCREASED61 reports
CHEST PAIN60 reports
BLINDNESS UNILATERAL57 reports
EXPIRED PRODUCT ADMINISTERED57 reports
MUSCLE SPASMS57 reports
HYPOTENSION56 reports
WHEEZING56 reports
PHOTOPHOBIA55 reports
BALANCE DISORDER54 reports
HAEMOGLOBIN DECREASED54 reports
MEMORY IMPAIRMENT52 reports
TREMOR50 reports
DRUG INTOLERANCE49 reports
MYALGIA49 reports
PRODUCT USE ISSUE49 reports
ATRIAL FIBRILLATION48 reports
CEREBROVASCULAR ACCIDENT48 reports
ABDOMINAL DISCOMFORT47 reports
LOSS OF CONSCIOUSNESS47 reports
ABDOMINAL PAIN46 reports
EYE DISCHARGE46 reports
COVID 1945 reports
PRODUCT DROPPER ISSUE45 reports
PRODUCT SUBSTITUTION ISSUE45 reports
ACCIDENTAL EXPOSURE TO PRODUCT44 reports
DIABETES MELLITUS44 reports
ABDOMINAL PAIN UPPER43 reports
BLOOD IMMUNOGLOBULIN E INCREASED43 reports

Report Outcomes

Out of 8,421 classified reports for TRAVOPROST:

Serious 36.5%Non-Serious 63.5%

The FDA classifies an adverse event as “serious” if it results in death, hospitalization, disability, congenital anomaly, or requires intervention to prevent permanent damage.

Demographics Breakdown

Reports by Sex

Female4,822 (61.0%)
Male3,052 (38.6%)
Unknown28 (0.4%)

Reports by Age

Age 73153 reports
Age 74108 reports
Age 72104 reports
Age 79103 reports
Age 8499 reports
Age 7696 reports
Age 7095 reports
Age 7194 reports
Age 7588 reports
Age 7785 reports
Age 7885 reports
Age 8185 reports
Age 6782 reports
Age 6881 reports
Age 8080 reports
Age 6975 reports
Age 8373 reports
Age 8266 reports
Age 8766 reports
Age 6361 reports

Demographics reflect voluntary FDA adverse event reporting patterns and may not represent the full patient population.

Frequently Asked Questions

How many FDA adverse event reports are associated with TRAVOPROST?

This profile reflects 13,183 FDA FAERS reports that mention TRAVOPROST. Reporting is voluntary and does not prove that the drug caused any listed event.

Which adverse reactions are most often listed for TRAVOPROST?

Frequently reported terms in FAERS include TREATMENT FAILURE, DRUG INEFFECTIVE, OCULAR HYPERAEMIA, EYE IRRITATION, EYE PAIN, INTRAOCULAR PRESSURE INCREASED. Rankings reflect reporting volume in this dataset, not confirmed side effect rates in the general population.

Who manufactures TRAVOPROST?

Labeling and FAERS entries often list Novartis Pharmaceuticals Corporation in connection with TRAVOPROST. Always verify the specific product and NDC with your pharmacist.

Important Disclaimer: This content is generated by AI analysis of FDA adverse event reports and is provided for informational purposes only. It is not medical advice. Adverse event reports submitted to the FDA do not prove that a medication caused the reported side effect. Always consult your healthcare provider before starting, stopping, or changing any medication. If you experience a serious side effect, contact your doctor or call 911 immediately.